Ionis Pharmaceuticals Inc
F:ISI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Ionis Pharmaceuticals Inc
F:ISI
|
US |
|
S
|
Sands China Ltd
XMUN:599A
|
MO |
|
G
|
Guangdong Investment Ltd
XMUN:GUG
|
HK |
|
S
|
Synchrony Financial
F:SFE
|
US |
|
I
|
Ionis Pharmaceuticals Inc
XMUN:ISI
|
US |
Intrinsic Value
Is ISI undervalued or overvalued?
See the intrinsic value estimate for 
Ionis Pharmaceuticals Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
ISI looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with ISI’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Ionis Pharmaceuticals Does
Ionis Pharmaceuticals is a drug company that makes medicines based on antisense technology, a way to turn off harmful proteins by targeting RNA before they are made. It spends most of its effort on discovering and developing treatments for serious diseases, especially rare genetic, neurological, cardiovascular, and metabolic conditions. Its pipeline is the main business asset: it creates drug candidates and then tests them through clinical development.
- Headquarters
- United States of America US
- Employees
- 1 402
- IPO date
- May 17, 1991
Ionis Pharmaceuticals has a narrow economic moat
Patents on Ionis’s medicines and the chemical designs behind them make it harder for rivals to copy some of its treatments. But other companies can compete with different medicines, so this protection is limited to particular products and designs.
Read the full moat analysis
Revenue & Expenses Breakdown
Ionis Pharmaceuticals Inc
Earnings Waterfall
Ionis Pharmaceuticals Inc
The intrinsic value for Ionis Pharmaceuticals Inc (ISI) under the Base Case is hidden EUR.
Compared with the current market price of 39.43 EUR, the stock appears hidden.